Catalyst Wire Dossier Catalyst Wire Dossier

olmesartan/hydrochlorothiazide

olmesartan; hydrochlorothiazide · Daiichi Sankyo
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for olmesartan/hydrochlorothiazide, covering 2009-04-20 to 2012-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker [Phase 4]

See pricing